Physician

Charlene D Murdakes, MD

According to 2025 Medicare claims, Charlene Murdakes, MD (NPI: 1992961593) practices nephrology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is RNA OF ROCKFORD, PLLC (NPI: 1336326388; TIN: 26-1497110) and primary practice location at 61107-5089. Murdakes is affiliated with the IRCCO (ACO ID: A2619) and OSF Healthcare System (ACO ID: A3289), participating under the MSSP model.

Murdakes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 888 traditional Medicare patients, billed 5,015 HCPCS/CPT codes, and received $298,160 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,593 prescription claims across 357 beneficiaries totaling $178,921 in drug costs, led by Farxiga (Dapagliflozin Propanediol). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $139,259 and ending at $178,921. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	670	7,731	$209,290
2016	766	8,253	$269,570
2017	755	5,405	$229,997
2018	716	6,687	$255,126
2019	893	4,375	$267,625
2020	963	3,657	$244,058
2021	831	4,444	$302,036
2022	838	4,585	$263,427
2023	874	3,048	$248,635
2024	888	5,015	$298,160

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	142	798	$139,259
2016	193	995	$201,482
2017	224	1,272	$158,651
2018	205	1,070	$103,989
2019	202	942	$95,003
2020	241	970	$70,917
2021	264	1,076	$84,854
2022	294	1,187	$123,572
2023	312	1,426	$169,302
2024	357	1,593	$178,921

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	499	693	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	160	441	$62
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	142	795	$50
99439	Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month	137	455	$38
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	557	786	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	96	4,952	$93,775
Lokelma	Sodium Zirconium Cyclosilicate	11	324	$12,245
Sevelamer Carbonate	Sevelamer Carbonate	22	1,620	$8,573
Calcium Acetate	Calcium Acetate	25	1,650	$2,462
Calcitriol	Calcitriol	214	14,274	$1,988

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Charlene D. Murdakes, MD?

Tedicare shows public-source Medicare data for Charlene D. Murdakes, MD (NPI 1992961593), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charlene D. Murdakes, MD have ACO affiliation data?

Charlene D. Murdakes, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and OSF Healthcare System (MSSP, ACO ID A3289).

What billing organization is linked to Charlene D. Murdakes, MD?

Charlene D. Murdakes, MD is linked to RNA OF ROCKFORD, PLLC (billing NPI 1336326388) in the available physician profile data.

Does Charlene D. Murdakes, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.